The Differential Diagnosis of Fetal Alcohol Spectrum Disorder

Main Article Content

Tom Leibson
Gal Neuman
Albert E Chudley
Gideon Koren

Keywords

FASD, differential diagnosis, pregnancy, ADHD, genetics

Abstract

Fetal Alcohol Spectrum Disorder (FASD) affects an estimated 1% of all children born in North America. FASD is a chronic disorder impacting many systems of care. Only a minority of these children exhibit the pathognomonic facial features of Fetal alcohol syndrome (FAS) that include short palpebral fissures, smooth philtrum and thin upper lip. Hence , in the majority of affected individuals FASD is a diagnosis of exclusion. The differential diagnosis of both the dysmorphological and neurobehavioral aspects of FASD is wide. This review aims to provide the pediatrician with information concerning the differential diagnosis of FASD and to discuss genetic testing that might be relevant to the assessment.

Abstract 22 | PDF Downloads 20

References

1) Jones KL, Hoyme HE, Robinson LK, Del Campo M, Manning MA, Prewitt LM, Chambers CD. Fetal alcohol spectrum disorders: Extending the range of structural defects. Am J Med Genet A 2010 Nov;152A(11):2731 - 5.
2) Douzgou S, Breen C, Crow YJ, Chandler K, Metcalfe K, Jones E, Kerr B, Clayton - Smith J. Diagnosing fetal alcohol syndrome: new insights from newer genetic technologies. Arch Dis Child 2012 Sep;97(9):812 - 7.
3) Abdelmal ik N, van Haelst M, Mancini G, Schrander - Stumpel C, Marcus - Soekarman D, Hennekam R, Cobben JM. Diagnostic outcomes of 27 children referred by pediatricians to a genetics clinic in the Netherlands with suspicion of fetal alcohol spectrum disorders. Am J Med Genet A 2013 Feb;161A(2):254 - 60. doi: 10.1002/ajmg.a.35672 Epub 2013 Jan 9.
4) Fryns JP. Aarskog syndrome: the changing phenotype with age. Am J Me Genet 1992; 43: 420 – 427.
5) Taub MB , Stanton A. Aarskog syndro me: a case report and literature review. Optom St Louis Mo 2008; 79; 371 – 377 .
6) Logie LJ . Porteous E. Intelligence and development in Aarskog syndrome. Arch Dis Child 1998; 79; 359 – 360.
7) Kaneko H , Kondo N. Clinical features of Bloom syndrome and function of the c ausative gene . BLM helicase. Exp Rev Mol Diagn 2004; 4: 393 – 401.
8) German J , Passarge E. Bloom’s syndrome. XII. Report from the Registry for 1987. Clin Gene. 1987; 35: 57 – 69 .
9) Houston CS , et al. The campomelic syndrome: review, report of 17 cases, and follow - up o n the currently 17 - year - old boy first reported by Maroteaux et al in 1971. Am J Med Gene 1983; 15: 3 – 28.
10) Gimovsky M , et al. Campomelic dysplasia: case report and review. J Perinatol 2008; 28: 71 – 73.
11) Scherer, Zabel B, Nishimura G. Clinical Utility Gene Card for : campomelic dysplasia. Eur J Hum Genet 2013; 21 (7) . doi: 10.1038/ejhg.2012.228
12) Kaur M , et al. Precocious sister chromatid separation (PSCS) in Cornelia de Lange syndrome. Am J Me Genet A 2005; 38 : 27 – 31.
13) Liu J , Krantz ID. Cornelia de Lange syndrome, cohesi n, and beyond. Clin Genet 2009; 76: 303 – 314.
14) Mannini L, Cucc F, Quarantotti V, Krantz I D, Musio A. Mutation s pectrum and g enotype - p henotype c orrelation in Cornelia de Lange Syndrome. Hum Mutat 2013. doi:10.1002/humu.22430
15) McDonald - McGinn DM , Sullivan KE. C hromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore)2011; 90: 1 – 18 .
16) Battaglia A. The inv dup(15) or idic(15) syndrome: a clinically recognisable neurogenetic disorder. Brain Dev 2005; 2: 365 – 369.
17) Borgatti R , et al. Relationship between clinical and genetic features in ‘inverted duplicated chromosome 15’ patients. Pediatr. Neurol 2001; 24: 111 – 116.
18) Tsukahara M , Opitz JM. Dubowitz syndrome: review of 141 cases including 36 previously unreported patients. Am. J Med Genet1996; 63: 277 – 289.
19) Parrish JM , Wilroy RS Jr. The Dubowitz syndrome: the psychological status of ten cases at follow - up. Am J Med Genet 1980; 6 : 3 – 8.
20) Huber RS, Houlihan D , Filter K. Dubowitz syndrome: a review and implications for cognitive, behavioral, a nd psychological features. J Clin Med Res 2011; 3: 147 – 155.
21) Orrison WW, Schnitzler ER , Chun RW. The Dubowitz syndrome: further observations. Am J Med Genet 1980; 7 : 155 – 170.
22) Graham JM Jr, Clark RD, Moeschler JB, Rogers RC. Behavioral features in young adults w ith FG syndrome (Opitz - Kaveggia syndrome). Am J Med Genet C Semin Med Genet 2010; 154C : 477 – 485.
23) Battaglia A, Chines C, Carey JC. The FG syndrome: report of a large Italian series. Am J Med Gene T A 2006; 140: 2075 – 2079.
24) McKusick VA. F loating Harbor Syndrome: FLHS 2013 at http://omim.org/entry/136140
25) White SM , et al. The phenotype of Floating - Harbor syndrome in 10 patients. Am J Med Genet A 2010; 152A : 821 – 829.
26) McKusick VA. GELEOPHYSIC DYSPLASIA 1 . GPHYSD1 2011 at http://omim.org/entry/231050
27) Le Goff C , et al. Mut ations in the TGFβ binding - protein - like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am J Hum Genet 2011; 89: 7 – 14.
28) Bögershausen N , Wollnik B. Unmasking Kabuki syndrome. Clin Genet 2013; 83: 201 – 211.
29) Chong SS , et al. A revision o f the lissencephaly and Miller - Dieker syndrome critical regions in chromosome 17p13.3. Hum Mol Genet 1997; 6; 147 – 155.
30) Roberts AE, Allanson JE, Tartaglia M, Gelb B D. Noonan syndrome. Lancet 2013; 381 : 333 – 342.
31) Joss SK , et al. Variable expression of neurologi cal phenotype in autosomal recessive oculodentodigital dysplasia of two sibs and review of the literature. Eur J Pediatr 2008; 167 : 341 – 345.
32) Quaderi NA , et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finge r gene on Xp22. Nat Genet 1997; 17 : 285 – 291.
33) Hsieh EWY, Vargervik K, Slavotinek AM. Clinical and molecular studies of patients with characteristics of Opitz G/BBB syndrome shows a novel MID1 mutation. Am J Me. Genet A 2008; 146A : 2337 – 2345.
34) Kosaki K, Curry C, Roeder E, Jones KL. Ritscher - Schinzel (3C) syndrome: documentation of the phenotype. Am J Med Genet 1997; 68: 421 – 427.
35) Leonardi ML, Pai GS, Wilkes B, Lebel RR. Ritscher - Schinzel cranio - cerebello - cardiac (3C) syndrome: report of four new cases and review. Am J Med. Genet 2011; 102: 237 – 242.
36) Kosho T , et al. Neonatal management of trisomy 18: clinical details of 24 patients receiving intensive treatment. Am J Med Genet A 2006; 140: 937 – 944.
37) Pont S J et al. Congenital malformations among liveborn infants with trisomi es 18 and 13. Am J MedGenet A. 2006; 140; 1749 – 1756 .
38) Pober BR. Williams - Beuren syndrome. N Engl J Med 2010; 362 : 239 – 252.
39) Gelineau - van Waes J, Bennett GD, Finnell H. Phenytoin - induced alterations in craniofacial gene expression. Teratology1999; 59 : 23 – 34.
40) Moo re SJ , et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000; 37 : 489 – 497.
41) Kozma C. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature . Am J Med Genet.2001; 98 : 168 – 175.
42) Scott TM, Fyfe WM, Hart DM. Maternal phenylketonuria: abnormal baby despite low phenylalanine diet during pregnancy. Arch Dis Child 1980; 55 : 634 – 637.
43) Rouse B , et al. Maternal Phenylketonuria Collaborative Study (MPKUCS) of fspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 1997; 69 : 89 – 95.
44) Pearson MA, Hoyme H , Seaver LH, Rimsza ME. Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 19 94; 93: 211 – 215.
45) Arnold GL, Kirby RS, Langendoerfer S , Wilkins - Haug L. Toluene embryopathy: clinical delineation and developmental follow - up. Pediatrics1994; 93: 216 – 220.
46) Costa LG, Guizzetti M, Burry M, Oberdoerster J. Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria. Toxicol Lett 2002; 127 : 197 – 205.
47) Steinau S. Diagnostic c riteria in a ttention d eficit h yperactivity d isorder - Changes in DS M 5. Front Psychiatry 2013; 4; 49.
48) Crocker N, Vaurio L, Riley EP, Mattson SN. Comparison of verbal learning and memory in children with heavy prenatal alcohol exposure or attention - deficit/hyperactivity disorder. Alcohol Clin Exp Res 2011; 35 : 1114 – 1121.
49) Vau ri L , Riley EP, Mattson SN. Differences in executive functioning in children with heavy prenatal alcohol exposure or attention - deficit/hyperactivity disorder. J Int Neuropsychol Soc 2008; 14 : 119 – 129.
50) Kooistra L , et al. Can attention deficit hyperactivity di sorder and fetal alcohol spectrum disorder be differentiated by motor and balance deficits? Hum Mov Sci 2009; 28 : 529 – 542.
51) Chudley AE , et al. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ 2005; 172 : S1 – S21.
52) Mayes SD, Calhoun SL, Crow ell EW. Learning disabilities and ADHD: overlapping spectrumn disorders. J Learn Disabil 2000; 33 : 417 – 424.
53) American Psychiatric Association & American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM - IV - TR . American Psychi atric Association, 2000.
54) Buitelaar JK , et al. Conduct disorders. Eu. Child Adolesc Psychiatry 2013; 22 Suppl : S49 – 54.
55) Nash K, Koren G . Rovet J. A differential approach for examining the behavioural phenotype of fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol 2011; 18 : e440 – 453.
56) Nash K , et al. Identifying the behavioural phenotype in Fetal Alcohol Spectrum Disorder: sensitivity, specificity and screening potential. Arch Womens Ment Health 2006; 9 :181 – 186.